LGL leukemia: from pathogenesis to treatment.
Lamy T, Moignet A, Loughran TP Jr.
Blood. 2017 Mar 2;129(9):1082-1094. doi: 10.1182/blood-2016-08-692590. Epub 2017 Jan 23.
Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
Hue SS, Oon ML, Wang S, Tan SY, Ng SB.
Pathology. 2020 Jan;52(1):111-127. doi: 10.1016/j.pathol.2019.09.011. Epub 2019 Nov 22.
[Clinical Characteristics of Aggressive NK-Cell Leukemia].
Liao Y, He HS, Wei YF, Shen DP, Ji XY, Huang C, Huang J, Jin XK, Huang DP.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Aug;31(4):1026-1031. doi: 10.19746/j.cnki.issn.1009-2137.2023.04.015.
Aggressive NK-cell leukemia with hemophagocytosis in a Caucasian patient.
Michaelis S, Pichler A, Stelzer I, Schöffmann L, Tinchon C, Enko D.
Ann Hematol. 2022 Mar;101(3):721-722. doi: 10.1007/s00277-021-04585-x. Epub 2021 Jul 16.
Single-cell RNA sequencing coupled to TCR profiling of large granular lymphocyte leukemia T cells.
Gao S, Wu Z, Arnold B, Diamond C, Batchu S, Giudice V, Alemu L, Raffo DQ, Feng X, Kajigaya S, Barrett J, Ito S, Young NS.
Nat Commun. 2022 Apr 11;13(1):1982. doi: 10.1038/s41467-022-29175-x.
[Allogeneic stem cell transplantation for aggressive NK cell leukemia].
Fujimoto A.
Rinsho Ketsueki. 2021;62(5):360-368. doi: 10.11406/rinketsu.62.360.
Possible Concomitant Aggressive NK Cell Leukemia and EBV-positive T-cell lymphoma; Using the online beta version of WHO-HAEM5 and videoconferencing software to make diagnoses accessible in an emerging economy.
Dayton VJ, Hoang Thien D, Xinh PT, Arries C, Sang NN, Linh NNN, Lien NP, Dung PC.
Diagn Pathol. 2023 Oct 6;18(1):111. doi: 10.1186/s13000-023-01395-9.
Allogeneic stem cell transplantation for patients with aggressive NK-cell leukemia.
Fujimoto A, Ishida F, Izutsu K, Yamasaki S, Chihara D, Suzumiya J, Mitsui T, Doki N, Sakai H, Kobayashi H, Kanda J, Fukuda T, Atsuta Y, Suzuki R.
Bone Marrow Transplant. 2021 Feb;56(2):347-356. doi: 10.1038/s41409-020-01009-8. Epub 2020 Aug 10.
Pure red cell aplasia.
Means RT Jr.
Blood. 2016 Nov 24;128(21):2504-2509. doi: 10.1182/blood-2016-05-717140.
STAT3 gain-of-function mutations connect leukemia with autoimmune disease by pathological NKG2D(hi) CD8(+) T cell dysregulation and accumulation.
Masle-Farquhar E, Jackson KJL, Peters TJ, Al-Eryani G, Singh M, Payne KJ, Rao G, Avery DT, Apps G, Kingham J, Jara CJ, Skvortsova K, Swarbrick A, Ma CS, Suan D, Uzel G, Chua I, Leiding JW, Heiskanen K, Preece K, Kainulainen L, O'Sullivan M, Cooper MA, Seppänen MRJ, Mustjoki S, Brothers S, Vogel TP, Brink R, Tangye SG, Reed JH, Goodnow CC.
Immunity. 2022 Dec 13;55(12):2386-2404.e8. doi: 10.1016/j.immuni.2022.11.001. Epub 2022 Nov 28.
